SULLIVAN GREGORY M 4
4 · Tonix Pharmaceuticals Holding Corp. · Filed Feb 27, 2025
Insider Transaction Report
Form 4
SULLIVAN GREGORY M
Chief Medical Officer
Transactions
- Other
Common Stock, par value $0.001
2025-02-05$1.47/sh−0.11$0→ 0 total - Award
Stock Option
2025-02-25+29,017→ 29,017 totalExercise: $10.06From: 2026-02-25Exp: 2035-02-25→ Common Stock (29,017 underlying) - Award
Stock Option
2025-02-25+29,017→ 29,017 totalExercise: $8.05From: 2026-02-25Exp: 2035-02-25→ Common Stock (29,017 underlying)
Footnotes (3)
- [F1]Involuntary sale of fractional shares following a reverse stock split of the Issuer's common stock
- [F2]One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months.
- [F3]The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan.